Sibayan, Normina B.
HRN: 22-40-25 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
12/29/2022
AMPICILLIN 1GM + SULBACTAM 500MG (VIAL)
12/29/2022
01/04/2023
IV
1.5g
Q6
CAP MR; Presumptive PTB; Mild Pleural Effusion, Right Prob Sec To #2
Waiting Final Action
Indication: Empiric Type of Infection: Pneumonia Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes